Neomycin Sulfate + BacitracinThird Party Manufacturing in India
Looking to get Neomycin Sulfate + Bacitracin manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.
Mechanism of Action
Neomycin Sulfate + Bacitracin works by combining two distinct antibacterial mechanisms to kill bacteria and prevent skin infections. Neomycin is an aminoglycoside antibiotic that binds to the bacterial 30S ribosomal subunit, causing misreading of transfer RNA and inhibiting protein synthesis in susceptible bacteria. Bacitracin is a polypeptide antibiotic that interferes with the dephosphorylation of C55-isoprenyl pyrophosphate, a molecule that transports peptidoglycan monomer subunits across the bacterial inner membrane. By blocking this transport, Bacitracin inhibits bacterial cell wall synthesis.
The combination of these two agents creates a broad spectrum of activity. Neomycin primarily targets gram-negative bacteria, while Bacitracin targets gram-positive bacteria, including staphylococci and streptococci. Unlike single-agent topicals, this combination provides dual-action protection against a wider variety of pathogens, lowering the risk of bacterial resistance. It is highly effective and well-tolerated for preventing infections in minor cuts, scrapes, and burns.
Therapeutic Uses & Indications
Therapeutic Uses
Neomycin Sulfate + Bacitracin is prescribed for the treatment of:
- Prevention of Infection: Preventing bacterial contamination in minor cuts, scrapes, abrasions, and superficial burns.
- Superficial Skin Infections: Treating localized bacterial skin infections caused by susceptible organisms.
- Infected Wounds: Secondary bacterial infections in minor wounds or skin tears.
Why Manufacturers Choose Neomycin Sulfate + Bacitracin
This combination is a staple in first-aid kits and OTC dermatological markets worldwide, driving high-volume manufacturing demand. The active pharmaceutical ingredients are highly stable when formulated in petrolatum-based ointment bases, ensuring a long shelf life. Manufacturers favor this formulation due to its established safety profile and broad market acceptance in both domestic OTC sales and international export tenders.
This makes Neomycin Sulfate + Bacitracin one of the most sought-after combinations for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.
Dosage Forms We Manufacture
Frequently Asked Questions
What is the minimum order quantity for Neomycin Sulfate + Bacitracin?
What dosage forms of Neomycin Sulfate + Bacitracin can you manufacture?
Are your manufacturing facilities WHO-GMP certified?
Can you manufacture Neomycin Sulfate + Bacitracin for export?
What grade standards do you follow for Neomycin Sulfate + Bacitracin?
Get Neomycin Sulfate + Bacitracin made under your brand
- WHO-GMP certified facilities
- Quote within 24 hours
- Low MOQ, export ready
+91 9689237122 · replies within hours
Our Manufacturing Capabilities
- WHO-GMP Certified Partner Plants
- 25+ years of pharma industry experience
- PCD Franchise with monopoly rights
- Export support across 25+ countries
- Small batch to commercial scale
- Custom formulation development
Packaging Options
Laminated aluminum tubes, plastic tubes, plastic jars, and sifter canisters for powder. Packaging customized to client brand guidelines.
Start Manufacturing Neomycin Sulfate + Bacitracin Today
Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Neomycin Sulfate + Bacitracin across all dosage forms. PCD franchise and export orders welcome.

